La anemia hemolítica autoinmune (AHAI) es una enfermedad poco frecuente en la edad pediátrica. Su diagnóstico se establece mediante la prueba de. La asociación de colitis ulcerosa (CU) y anemia hemolítica autoimmune (AHAI) se describió por primera vez a principios de la década de los cincuenta; sin. Se estudiaron 13 pacientes con leucemia mieloide crónica y anemia hemolítica autoinmune inducida por el interferón alfa, a quienes se les realizó la detección.
|Published (Last):||16 March 2017|
|PDF File Size:||6.15 Mb|
|ePub File Size:||1.74 Mb|
|Price:||Free* [*Free Regsitration Required]|
The role of rituximab in adults with warm antibody autoimmune hemolytic anaemia.
Anemia Hemolítica Autoinmune | Medical City McKinney
Rev Cubana Hematol Inmunol Hemoter. Rituximab in Refractory Autoimmune Hemolytic Anemia in This item has received. There was a negative correlation between Hb and plasma haptoglobin values with the number of IgG molecules per erythrocyte and a positive correlation between the latter with the reticulocyte count. High incidence of autoimmune alterations in chronic myeloid leukemia patients treated with interferon- a. Lower dose of rituximab in the treatment of elderly autoinmune hemolytic anemia.
There was a problem providing the content you requested
Previous article Next article. Rituximab therapy has a rapid hemoitica durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus. Si continua navegando, consideramos que acepta su uso. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. CiteScore measures average citations received per document published.
Rheumatoid Arthritis and Ocular Myasthenia Gravis Rituximab in refractory autoimmune hemolytic anemia in systemic lupus erythematosus. Petz LD, Garraty G.
Interferon in oncology practice: Rituximab in the treatment of autoimmune haemolytic anaemia. Interferon in chronic myeloid leukaemia: The mechanism of action appears to be linked with the selective B-cell depletion and the lowering of autoantibody levels.
Successful induction and maintenance of long-term remission in a child with chronic relapsing autoinmune hemolytic anemia using rituximab. The treatment of these autoimmune haemolytic anaemias with rituximab requires authorisation by the Spanish Ministry of Health for compassionate ehmolitica.
Br J Haematol,pp. SRJ is a prestige metric based on the idea that not all citations are the same. You can change the settings or obtain more information by clicking here.
Am J Hematol, 84pp. American Association of Blood Banks; Raanani P, Ben-Bassat I. Immune-mediated and unusual complications during interferon alpha therapy in chronic myelogenous leukemia.
Anemia Hemolítica Autoinmune
Treatment of AIHA, especially in cold antibody-mediated disease, represents a therapeutical challenge. Haemolytic anemia to the alpha interferon treatment: A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia.
Controlling autoimmunity–Lessons from the study of red blood cells as model antigens. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoinmune hemolytic anemia.
DESTACAN LA UTILIDAD DEL RITUXIMAB PARA TRATAR LA ANEMIA HEMOLITICA AUTOIMMUNE
Continuing navigation will be considered as acceptance of this use. The James Blundell Award Lecture Retrospective analysis of 27 cases. American Red Cross; Inmunologia celular y molecular. Are you a health professional able to prescribe or dispense drugs? Ann Hematol, 89pp.
Rev Cub Hematol Inmunol Hemoter. N Engl J Med. To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. In high-grade hemolysis patients, it was found a concentration of autoantibodies between 1 and 3 molecules of IgG per erythrocyte, while in low-grade hemolysis patients it behaved between and 1 molecules.
SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
Published studies are primarily clinical and epidemiological research but also basic. Tel, Fax Therefore, properly designed clinical trials evaluating rituximab as salvage- and first-line-therapy for the treatment of AIHA and cold agglutinin disease are clearly warranted.
It was detected the presence of IgG and C3 in Key words autoimmune haemolytic anaemia, cold agglutinin disease, rituximab. Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia. Br J Clin Pharmacol, 79pp. Blood,pp. Quantitation aspect of destruction of red cell sensitized with IgG1 autoantibodies an aplication of flow cytofluorometry.